Breast gangrene is a very rare disease and only a few cases have been reported in the Indian literature. Here, we present the case of a 70-year-old married female presented with complaints of pain and blackish discoloration in the right breast for 3 days. The surgery was planned on the same day with incision and drainage. Intraoperative findings were suggestive of sloughed and necrosed underlying tissue. The wound was left open and the daily dressing was planned. Then, wound closed. The patient was discharged on the 7 th postoperative day. Surgeons should be aware of such ailments because breast gangrene is very rare.
Myxoid pleomorphic sarcoma is categorized as a soft-tissue sarcoma that most commonly appears in the lower extremities during adulthood, but rarely in the feet. We present a rare case of a primary myxoid pleomorphic sarcoma in the foot of a 45-year-old female which was rare in females. On examination, a ulceroproliferative growth of around 10 cm × 12 cm size was seen over the posterior aspect of foot involving the whole ankle region, with a thickened scar over the plantar and medial aspect of the right foot. Magnetic resonance imaging of the mass revealed a high signal intensity on T1-weighted images and heterogeneously high signal intensity on T2-weighted images without fat suppression. Histology showed variable cellularity, myxoid granular to the filamentous background, and round to spindled tumor cells. The immunohistochemistry showed positive for vimentin, acid mucins, CD34, and negative for S100. Hence, these findings were consistent with myxoid pleomorphic sarcoma. The patient was treated with below-knee amputation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.